In Vivo Fluorescence Tracking of Bone Marrow Stromal Cells Transplanted into a Pneumatic Injury Model of Rat Spinal Cord
Overview
Neurology
Authors
Affiliations
Recent experimental studies have shown that bone marrow stromal cells (BMSC) differentiate into neural cells and reduce neurological deficits when transplanted into traumatized spinal cord. These findings have been derived primarily from histological analyses. We conducted a study directed chiefly at developing a non-invasive system for tracking BMSC transplanted into the spinal cord of living animals. In this study, we induced spinal cord injury (SCI) in rats with a pneumatic device. BMSC were harvested from transgenic mice expressing green fluorescence protein (BMSC-GFP), and were transplanted stereotactically into a control group of rats without SCI (n = 6) and a group with SCI (n = 3). At 2 and 4 weeks after transplantation, the dura mater was exposed and green fluorescence derived from the transplanted BMSC-GFP was observed. The distribution and differentiation of the transplanted cells were subsequently evaluated with immunohistochemistry. Green fluorescence could be detected around the transplantation site in three of six of the control rats. In all three rats subjected to SCI, green fluorescence was shown to spread from the site of BMSC-GFP injection toward the injury site, suggesting that the transplanted cells had migrated toward the lesion within the 4-week post-transplantation period. Histological evaluation suggested that the detected green fluorescence was emitted by cells that had distributed in the dorsal white matter, and demonstrated that some of the transplanted cells expressed neuronal or astrocytic markers. These results suggest the possibility of tracking BMSC transplanted into the spinal cord in living animals. Such noninvasive bioimaging techniques would be valuable for monitoring the fate of these transplanted cells and assessing the safety and efficacy of their transplantation.
Farid M, Abouelela Y, Yasin N, Al-Mokaddem A, Prince A, Ibrahim M Stem Cell Res Ther. 2023; 14(1):6.
PMID: 36627662 PMC: 9832640. DOI: 10.1186/s13287-022-03222-2.
imaging in experimental spinal cord injury - Techniques and trends.
Hubertus V, Meyer L, Roolfs L, Waldmann L, Nieminen-Kelha M, Fehlings M Brain Spine. 2022; 2:100859.
PMID: 36248104 PMC: 9560701. DOI: 10.1016/j.bas.2021.100859.
Elucidating the Pivotal Neuroimmunomodulation of Stem Cells in Spinal Cord Injury Repair.
Richard S, Sackey M Stem Cells Int. 2021; 2021:9230866.
PMID: 34341666 PMC: 8325586. DOI: 10.1155/2021/9230866.
Amorim R, Clark K, Walker N, Kumar P, Herout K, Borjesson D Stem Cell Res Ther. 2020; 11(1):304.
PMID: 32698861 PMC: 7374910. DOI: 10.1186/s13287-020-01799-0.
Cell Therapy for Stroke: Review of Previous Clinical Trials and Introduction of Our New Trials.
Shichinohe H, Houkin K Neurol Med Chir (Tokyo). 2016; 56(10):592-596.
PMID: 27302193 PMC: 5066079. DOI: 10.2176/nmc.st.2016-0087.